Transanal Total Mesorectal Excision in Lower Rectal Cancer: Comparison of Short-Term Outcomes with Conventional Laparoscopic Total Mesorectal Excision

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: Transanal total mesorectal excision (TaTME) is a novel technique to treat rectal cancer and also to obtain good-quality specimens. This study investigated the clinical results and perioperative and pathological outcomes of TaTME in lower rectal cancer treatment in comparison with laparoscopic total mesorectal excision (LaTME). Methods: During January 2014 to May 2017, all consecutive patients with lower rectal cancer who underwent TaTME were identified. This cohort study was matched for age, gender, American Society of Anesthesiology (ASA) score, and clinical staging with a cohort of patients who underwent conventional LaTME. Results: A total of 46 patients were analyzed in both groups. There were no significant differences in baseline characteristics between the groups. The estimated blood loss, duration of operation, and postoperative complications were also not different between both groups. Regarding pathological outcomes, no patients with circumferential margin (CRM) <1 mm were observed in the TaTME group compared to 4 patients with CRM <1 mm in the LaTME group (P = .037). Conclusion: TaTME is a safe and feasible procedure in this matched case-control study. TaTME had better pathological outcomes with CRM uninvolvement compared with laparoscopic surgery.

Original languageEnglish
Pages (from-to)365-369
Number of pages5
JournalJournal of Laparoendoscopic and Advanced Surgical Techniques
Volume28
Issue number4
DOIs
Publication statusPublished - Apr 1 2018

Fingerprint

Rectal Neoplasms
Anesthesiology
Laparoscopy
Case-Control Studies
Cohort Studies
Therapeutics

Keywords

  • laparoscopy
  • rectal cancer
  • TME
  • transanal

ASJC Scopus subject areas

  • Surgery

Cite this

@article{c04870b6b7e849eca9f6a902858498a4,
title = "Transanal Total Mesorectal Excision in Lower Rectal Cancer: Comparison of Short-Term Outcomes with Conventional Laparoscopic Total Mesorectal Excision",
abstract = "Background: Transanal total mesorectal excision (TaTME) is a novel technique to treat rectal cancer and also to obtain good-quality specimens. This study investigated the clinical results and perioperative and pathological outcomes of TaTME in lower rectal cancer treatment in comparison with laparoscopic total mesorectal excision (LaTME). Methods: During January 2014 to May 2017, all consecutive patients with lower rectal cancer who underwent TaTME were identified. This cohort study was matched for age, gender, American Society of Anesthesiology (ASA) score, and clinical staging with a cohort of patients who underwent conventional LaTME. Results: A total of 46 patients were analyzed in both groups. There were no significant differences in baseline characteristics between the groups. The estimated blood loss, duration of operation, and postoperative complications were also not different between both groups. Regarding pathological outcomes, no patients with circumferential margin (CRM) <1 mm were observed in the TaTME group compared to 4 patients with CRM <1 mm in the LaTME group (P = .037). Conclusion: TaTME is a safe and feasible procedure in this matched case-control study. TaTME had better pathological outcomes with CRM uninvolvement compared with laparoscopic surgery.",
keywords = "laparoscopy, rectal cancer, TME, transanal",
author = "Chang, {Tung Cheng} and Kiu, {Kee Thai}",
year = "2018",
month = "4",
day = "1",
doi = "10.1089/lap.2017.0520",
language = "English",
volume = "28",
pages = "365--369",
journal = "Journal of Laparoendoscopic and Advanced Surgical Techniques - Part A",
issn = "1092-6429",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - Transanal Total Mesorectal Excision in Lower Rectal Cancer

T2 - Comparison of Short-Term Outcomes with Conventional Laparoscopic Total Mesorectal Excision

AU - Chang, Tung Cheng

AU - Kiu, Kee Thai

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Background: Transanal total mesorectal excision (TaTME) is a novel technique to treat rectal cancer and also to obtain good-quality specimens. This study investigated the clinical results and perioperative and pathological outcomes of TaTME in lower rectal cancer treatment in comparison with laparoscopic total mesorectal excision (LaTME). Methods: During January 2014 to May 2017, all consecutive patients with lower rectal cancer who underwent TaTME were identified. This cohort study was matched for age, gender, American Society of Anesthesiology (ASA) score, and clinical staging with a cohort of patients who underwent conventional LaTME. Results: A total of 46 patients were analyzed in both groups. There were no significant differences in baseline characteristics between the groups. The estimated blood loss, duration of operation, and postoperative complications were also not different between both groups. Regarding pathological outcomes, no patients with circumferential margin (CRM) <1 mm were observed in the TaTME group compared to 4 patients with CRM <1 mm in the LaTME group (P = .037). Conclusion: TaTME is a safe and feasible procedure in this matched case-control study. TaTME had better pathological outcomes with CRM uninvolvement compared with laparoscopic surgery.

AB - Background: Transanal total mesorectal excision (TaTME) is a novel technique to treat rectal cancer and also to obtain good-quality specimens. This study investigated the clinical results and perioperative and pathological outcomes of TaTME in lower rectal cancer treatment in comparison with laparoscopic total mesorectal excision (LaTME). Methods: During January 2014 to May 2017, all consecutive patients with lower rectal cancer who underwent TaTME were identified. This cohort study was matched for age, gender, American Society of Anesthesiology (ASA) score, and clinical staging with a cohort of patients who underwent conventional LaTME. Results: A total of 46 patients were analyzed in both groups. There were no significant differences in baseline characteristics between the groups. The estimated blood loss, duration of operation, and postoperative complications were also not different between both groups. Regarding pathological outcomes, no patients with circumferential margin (CRM) <1 mm were observed in the TaTME group compared to 4 patients with CRM <1 mm in the LaTME group (P = .037). Conclusion: TaTME is a safe and feasible procedure in this matched case-control study. TaTME had better pathological outcomes with CRM uninvolvement compared with laparoscopic surgery.

KW - laparoscopy

KW - rectal cancer

KW - TME

KW - transanal

UR - http://www.scopus.com/inward/record.url?scp=85045332308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045332308&partnerID=8YFLogxK

U2 - 10.1089/lap.2017.0520

DO - 10.1089/lap.2017.0520

M3 - Article

AN - SCOPUS:85045332308

VL - 28

SP - 365

EP - 369

JO - Journal of Laparoendoscopic and Advanced Surgical Techniques - Part A

JF - Journal of Laparoendoscopic and Advanced Surgical Techniques - Part A

SN - 1092-6429

IS - 4

ER -